DENTSPLY SIRONA (NASDAQ:XRAY) Director Purchases $186,750.00 in Stock

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Director Gregory Lucier acquired 15,000 shares of DENTSPLY SIRONA stock in a transaction dated Monday, March 9th. The stock was purchased at an average cost of $12.45 per share, with a total value of $186,750.00. Following the completion of the purchase, the director owned 65,000 shares of the company’s stock, valued at approximately $809,250. This represents a 30.00% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ XRAY traded up $0.06 during mid-day trading on Monday, reaching $12.80. The company’s stock had a trading volume of 3,590,550 shares, compared to its average volume of 4,989,556. The company has a debt-to-equity ratio of 1.50, a current ratio of 1.51 and a quick ratio of 1.03. DENTSPLY SIRONA Inc. has a 52 week low of $9.85 and a 52 week high of $17.18. The stock has a fifty day moving average of $12.63 and a two-hundred day moving average of $12.45. The firm has a market capitalization of $2.56 billion, a PE ratio of -4.27, a P/E/G ratio of 1.49 and a beta of 0.97.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, February 26th. The medical instruments supplier reported $0.27 EPS for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.01). DENTSPLY SIRONA had a positive return on equity of 18.85% and a negative net margin of 16.25%.The business had revenue of $961.00 million during the quarter, compared to analysts’ expectations of $926.40 million. During the same period in the prior year, the firm posted $0.26 earnings per share. The firm’s revenue for the quarter was up 6.2% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. As a group, sell-side analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, January 9th. Investors of record on Friday, December 26th were paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 5.0%. The ex-dividend date of this dividend was Friday, December 26th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -21.33%.

Analyst Ratings Changes

Several research analysts have commented on XRAY shares. Barrington Research increased their price objective on shares of DENTSPLY SIRONA from $14.00 to $17.00 and gave the company an “outperform” rating in a report on Monday, March 2nd. Barclays began coverage on DENTSPLY SIRONA in a research report on Monday, December 8th. They issued an “underweight” rating and a $12.00 target price on the stock. UBS Group dropped their price target on DENTSPLY SIRONA from $17.00 to $16.00 and set a “buy” rating for the company in a research note on Tuesday, February 3rd. Robert W. Baird lifted their price objective on DENTSPLY SIRONA from $12.00 to $14.00 and gave the stock a “neutral” rating in a research note on Friday, February 27th. Finally, Mizuho upped their price objective on DENTSPLY SIRONA from $14.00 to $16.00 and gave the stock a “neutral” rating in a report on Monday, March 2nd. Three investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $14.42.

Institutional Investors Weigh In On DENTSPLY SIRONA

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Parkside Financial Bank & Trust boosted its stake in shares of DENTSPLY SIRONA by 620.6% in the second quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock worth $27,000 after buying an additional 1,477 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new position in DENTSPLY SIRONA during the first quarter valued at approximately $26,000. Eurizon Capital SGR S.p.A. acquired a new position in DENTSPLY SIRONA in the fourth quarter valued at approximately $26,000. True Wealth Design LLC lifted its holdings in DENTSPLY SIRONA by 273.0% in the second quarter. True Wealth Design LLC now owns 2,376 shares of the medical instruments supplier’s stock valued at $38,000 after acquiring an additional 1,739 shares during the period. Finally, Caitong International Asset Management Co. Ltd boosted its position in DENTSPLY SIRONA by 337.9% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 2,750 shares of the medical instruments supplier’s stock worth $35,000 after purchasing an additional 2,122 shares in the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.